sugammadex amomed
aop orphan pharmaceuticals gmbh - sugammadex sodium - neuromuskulær blokkade - alle andre terapeutiske produkter - reversering av nevromuskulær blokade indusert av rocuronium eller vecuronium. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.
sugammadex piramal
piramal critical care b.v. - sugammadex sodium - neuromuskulær blokkade - sugammadex - reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults.
sugammadex adroiq
extrovis eu ltd. - sugammadex sodium - neuromuskulær blokkade - alle andre terapeutiske produkter - reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.
sugammadex baxter 100 mg/ ml
baxter holding b.v. - sugammadeksnatrium - injeksjonsvæske, oppløsning - 100 mg/ ml
sugammadex bioglan 100 mg/ ml
bioglan ab - sugammadeksnatrium - injeksjonsvæske, oppløsning - 100 mg/ ml
sugammadex teva 100 mg/ ml
teva b.v. - sugammadeksnatrium - injeksjonsvæske, oppløsning - 100 mg/ ml
fentanyl hameln 50 mikrog/ ml
siegfried hameln gmbh - fentanylsitrat - injeksjonsvæske, oppløsning - 50 mikrog/ ml
amikacin macure 250 mg/ ml
macure pharma aps - amikacinsulfat - injeksjonsvæske, oppløsning - 250 mg/ ml
isocare vet 1000 mg/ g
ecuphar nv - isofluran - væske til inhalasjonsdamp - 1000 mg/ g
ringer-acetat fresenius kabi
fresenius kabi norge as - halden - natriumklorid / natriumacetattrihydrat / kaliumklorid / kalsiumkloriddihydrat / magnesiumkloridheksahydrat - infusjonsvæske, oppløsning - 5.9 g/ l / 4.1 g/ l / 0.3 g/ l / 0.295 g/ l / 0.2 g/ l